hartleys recommends pyc as spec buy, page-2

Fancy science indeed. Good investing for the ordinary blokes hard earned? Probably not.

The "frontier" past and present is littered with failures who got in on the next big thing and then came unstuck somehow. The mode of which could be, technological failure or shift, patent protection and lack of, loss of key people, power shifts in the market place and boardroom, continual dilution of equity or a good old fashioned takeover for pennies in the dollar of its real worth.

The reward here is not reflective of the actual risk unless they have something they aren't telling us from the Roche deal. Like truckloads of upfront cash...which I doubt...otherwise they would be telling us because they are lawfully bound to.

End of story.